new warnings, again, about using inhaled long-acting beta-agonists (Serevent, etc) for asthma

January 2009

Please see the FDA's new recommendations for the use of long-acting beta agonists

You'll see new warnings, again, about using inhaled long-acting beta-agonists (Serevent, etc) for asthma.

These drugs already have a black box warning about a possible increased risk of severe asthma attacks and death.

This is seen when inhaled long-acting beta-agonists are used ALONE for asthma...instead of with an inhaled corticosteroid.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote